Post-Parathyroidectomy Management: Calcium & Vitamin D (Updated through 2025)

Why Hypocalcemia Happens After Parathyroidectomy

1. Hypoparathyroidism - reduced PTH impairs renal calcium reabsorption, reduces intestinal calcium absorption (via reduced calcitriol synthesis), and decreases bone resorption.
2. Hungry Bone Syndrome (HBS) - especially after surgery for hyperparathyroidism. With PTH suddenly withdrawn, bones rapidly recalcify, pulling calcium out of the bloodstream. This can cause prolonged, severe hypocalcemia lasting weeks to months. Large amounts of calcium and active vitamin D are required for extended periods, with regular monitoring. - Comprehensive Clinical Nephrology, 7th Ed.

Preoperative Prevention (Before November 2025 Surgery)

• Correct vitamin D deficiency before surgery. Correcting vitamin D deficiency has been shown to reduce both the incidence of post-operative hypocalcemia and hospital length of stay. Target serum 25-OH vitamin D >50 nmol/L. - Scott-Brown's Otorhinolaryngology, Vol. 1
• For high-risk cases (large adenoma, high bone turnover), some protocols use calcitriol 2 mcg/24h for 5 days pre-op plus calcium 2-3 g/24h for 2 days pre-op to enhance intestinal absorption peaking at the time of surgery. - AJCR 2026 case review

Immediate Post-op Assessment (First 4-6 Hours)

Acute Symptomatic Hypocalcemia - IV Treatment

1. Check phosphorus - if severely elevated (>6.5 mg/dL), pushing calcium can worsen ectopic calcification. May need dialysis first.
2. Check and replace magnesium first - hypomagnesemia blocks PTH release and makes hypocalcemia refractory.

• Calcium gluconate (10% solution, 10 mL ampoule = 90 mg elemental calcium) is preferred over calcium chloride - less tissue necrosis on extravasation.
• For severe/symptomatic: continuous calcium gluconate infusion until oral therapy is tolerated.
• Washington Manual of Medical Therapeutics

Chronic/Outpatient Management

1. Oral Calcium Supplements

• Calcium carbonate requires acid for absorption - take WITH food (or with meals for phosphate binding benefit).
• Calcium citrate can be taken without food.
• Target: 1-2 g elemental calcium per day (can go up to 3 g/day in HBS).
• Washington Manual / Healio Clinical Guidance 2025

2. Active Vitamin D (Essential in Hypoparathyroidism)

• Monitor phosphorus as calcitriol also increases phosphate absorption - add phosphate binders if phosphorus rises above normal.
• Also supplement with parent vitamin D (cholecalciferol or ergocalciferol) to correct any underlying deficiency - this does not replace calcitriol.
• Washington Manual; Healio Clinical Guidance

3. Parent Vitamin D (Adjunct)

• Simple dietary deficiency: ergocalciferol or cholecalciferol 400-1000 IU/day.
• Severe deficiency / malabsorption: 50,000 IU weekly for 6-8 weeks (ergocalciferol).
• This does NOT replace calcitriol in hypoparathyroidism - both are needed.

Monitoring Schedule

Special Situation: Hungry Bone Syndrome

• Can persist for weeks to months post-parathyroidectomy.
• Large IV and oral calcium supplementation required.
• Concomitant oral calcitriol before and after surgery can mitigate severity. - NKF Primer on Kidney Diseases
• Monitor for hypophosphatemia (another feature of HBS alongside hypocalcemia).
• Gradual step-down of supplements only once serum calcium is consistently normal.

Emerging Therapies (2025)

• TransCon PTH (palopegteriparatide): long-acting PTH replacement. Phase 3 PaTHway trial 52-week results published 2025 - showed sustained normal calcium with reduced hypercalciuria versus conventional therapy. (J Clin Endocrinol Metab 2025)
• Eneboparatide: new PTH analogue - met primary endpoint normalizing serum calcium at 24 weeks in CALYPSO Phase III trial (AstraZeneca, March 2025).
• These PTH replacement therapies are being positioned as alternatives to conventional calcitriol + calcium, particularly for permanent hypoparathyroidism.

Summary Algorithm

Post-Parathyroidectomy / Post-Thyroidectomy
           ↓
  Check PTH at 4 hours post-op
           ↓
PTH >30 → Calcium carbonate alone
PTH 15-30 → Calcium carbonate + Low-dose calcitriol
PTH <15 → Calcium carbonate + High-dose calcitriol
           ↓
Symptomatic? → IV calcium gluconate infusion
           ↓
Chronic: Oral Ca 500-1000 mg 2-3x/day + Calcitriol 0.25-2 mcg/day
           ↓
Correct Mg if refractory. Monitor Ca, PO4, urine Ca regularly.
           ↓
HBS suspected? → High-dose Ca + calcitriol for weeks-months

• Scott-Brown's Otorhinolaryngology, Vol. 1 - Post-operative Hypoparathyroidism
• Washington Manual of Medical Therapeutics - Hypocalcemia Treatment
• Brazilian Society 2024 Practice Guideline on Acute Hypoparathyroidism after Thyroid Surgery (PMID 39315485)
• Chindris AM et al., Endocrine Practice 2025 - PTH-guided protocol reducing hypocalcemia from 21% to 9.5% (PMID 40633692)
• Healio Clinical Guidance on Hypoparathyroidism Pharmacological Interventions, updated 2025

Why Calcitriol (Not Plain Vitamin D) After Parathyroidectomy

The Normal Vitamin D Activation Pathway

Skin / Diet
    ↓
Vitamin D3 (cholecalciferol) - INACTIVE
    ↓  [Liver - 25-hydroxylation]
25-hydroxyvitamin D (calcidiol) - STORAGE FORM, still inactive
    ↓  [Kidney - 1α-hydroxylation → controlled by PTH]
1,25-dihydroxyvitamin D = CALCITRIOL - ACTIVE FORM

The Problem After Parathyroidectomy

• PTH drops to near zero
• The kidney's 1α-hydroxylase enzyme is no longer stimulated
• Therefore, the conversion of 25-OH vitamin D → calcitriol is blocked
• Even if you give large doses of cholecalciferol (plain vitamin D3), it cannot be activated into calcitriol
• The patient effectively has impaired 1α-hydroxylation - this is specifically listed under causes of vitamin D deficiency alongside Hypoparathyroidism in Harrison's 22nd Edition (2025)

Why Calcitriol Bypasses This Problem

• The intestine → increases calcium absorption
• The kidney → promotes calcium reabsorption
• The bone → regulates bone mineralization

Plain Vitamin D3 vs Calcitriol - Head-to-Head

Practical Point - Plain Vitamin D3 Is Still Given Too

• D3 has non-calcium effects (immune function, muscle, cancer protection) acting through peripheral tissue VDRs
• Baseline vitamin D stores should be maintained (25-OH D target >50 nmol/L)
• But it cannot replace calcitriol for calcium homeostasis in hypoparathyroidism

Dengue Fever - Complete Management Guide

Overview

Classification (WHO / CDC 2025)

• Abdominal pain or tenderness
• Persistent vomiting
• Clinical fluid accumulation (ascites, pleural effusion)
• Mucosal bleeding
• Lethargy / restlessness
• Liver enlargement >2 cm
• Rising hematocrit with rapid drop in platelet count

• Severe plasma leakage → dengue shock syndrome (DSS)
• Severe bleeding (e.g., GI bleed)
• Severe organ impairment (liver: AST/ALT >1000, CNS: impaired consciousness, heart, kidneys)

The Three Clinical Phases

Febrile Phase (Days 1-3)      → high fever, myalgia, rash, headache
Critical Phase (Days 4-6)     → defervescence, plasma leakage, shock risk
Recovery Phase (Days 7-10)    → reabsorption of leaked fluid, risk of fluid overload

Group A Management (Outpatient)

• Oral hydration - oral rehydration salts (ORS), fruit juices, soups. Target 2-3 L/day in adults.
• Paracetamol for fever and pain (10-15 mg/kg/dose, max 4 g/day).
• AVOID NSAIDs (ibuprofen, aspirin, diclofenac) - increases bleeding risk due to antiplatelet and gastric effects. - Tintinalli's Emergency Medicine
• AVOID corticosteroids - no proven benefit.
• Review daily if symptoms persist >3 days, or immediately if any warning sign develops.
• Monitor: FBC every 24-48h (watch for rising haematocrit and falling platelets).

Group B Management (Inpatient)

• Start isotonic crystalloid (Ringer's Lactate preferred, or 0.9% Normal Saline)
• Initial rate: 5-7 mL/kg/hour for 1-2 hours
• Reduce to 3-5 mL/kg/h if improving → then 2-3 mL/kg/h
• Do NOT use hypotonic fluids (risk of hyponatremia with capillary leak)
• Switch to oral as soon as patient tolerates it

• Vital signs every 1-2 hours
• Hematocrit every 4-6 hours (rising HCT = worsening plasma leak; falling HCT despite fluid = occult bleeding)
• Urine output: target 0.5-1 mL/kg/hour
• Platelet count daily (or more frequently)

• Blood pressure, pulse, perfusion stable
• Haematocrit falls with good pulse volume
• Afebrile >24-48h without antipyretics
• Resolving abdominal symptoms
• Good urine output
• Continuing IV fluids beyond 48h of critical phase causes fluid overload - [WHO/CENAPRECE 2025]

Group C Management (Severe Dengue / Shock)

• Immediate fluid resuscitation: isotonic crystalloid 10 mL/kg over 1 hour (adults); reassess every 15-30 min
• If no improvement: repeat bolus 10-20 mL/kg; consider colloid (dextran 40 or starch) if persistent shock despite 2-3 crystalloid boluses
• If haematocrit falls (suggesting bleeding): consider blood transfusion (packed RBCs 10 mL/kg)
• After resuscitation: taper IV fluids carefully to avoid rebound fluid overload in recovery phase
• Admit to ICU; monitor: pulse pressure, capillary refill time, mental status, HCT, lactate

Platelet Transfusion - 2025 Guidelines

"In patients with consumptive thrombocytopenia due to dengue without major bleeding, platelet transfusion is not recommended." - AABB 2025 Guidelines (PMID 40440268)

What NOT to Use in Dengue

Monitoring Parameters Summary

Discharge Criteria

• Afebrile for at least 24 hours (without antipyretics)
• No warning signs for at least 24 hours
• Good urine output
• No clinical fluid accumulation
• Haematocrit stable and improving
• Platelet count rising and above 50,000/µL
• Tolerating oral fluids well

Special Situations

• Tintinalli's Emergency Medicine - Dengue Fever section
• Comprehensive Clinical Nephrology, 7th Ed. - Dengue-associated AKI
• WHO July 2025 - Clinical Management of Arboviral Diseases
• CDC Dengue Clinical Care 2025
• AABB/ICTMG 2025 Platelet Transfusion Guidelines, JAMA 2025 (PMID 40440268) - Do NOT transfuse platelets prophylactically in dengue

Can Monocef-SB (Ceftriaxone + Sulbactam) Be Given in Dengue?

What Is Monocef-SB?

• Ceftriaxone - 3rd generation cephalosporin (broad-spectrum antibacterial, covers Gram-positive and Gram-negative organisms)
• Sulbactam - beta-lactamase inhibitor (protects ceftriaxone from bacterial enzyme degradation, extends coverage to resistant organisms)
• Together: covers a wide range of bacteria including many resistant strains

In Pure Dengue - Do NOT Use

• Treating the dengue virus
• Preventing dengue complications (plasma leakage, thrombocytopenia, shock)
• Raising platelet count

The Critical Problem: Ceftriaxone Can Worsen Thrombocytopenia

• Worsen the thrombocytopenia further
• Make it very difficult to distinguish drug-induced vs. dengue-induced platelet fall
• Increase bleeding risk

When IS Monocef-SB Justified in a Dengue Patient?

Putting It in Context: Your Patient (Post-Parathyroidectomy with Dengue)

• Dengue itself - no antibiotics needed
• Post-surgical wound infection or sepsis - antibiotics warranted, but choose based on likely organism and sensitivity
• Monocef-SB specifically - be cautious because:
  • Patient likely already has post-surgical stress, possible electrolyte imbalance
  • Ceftriaxone can cause DIIT - in a dengue patient with low platelets, this is a significant additive risk
  • Ceftriaxone also causes pseudolithiasis (biliary sludge) which can complicate abdominal monitoring
  • Ceftriaxone can elevate liver enzymes - dengue already causes hepatitis; combined effect may confuse monitoring

Safer Alternatives If Antibiotic Is Truly Needed

• Amoxicillin-clavulanate (oral) - for mild-moderate bacterial infections without resistance concerns
• Piperacillin-tazobactam - for hospital-acquired infections (though piperacillin also has DIIT potential)
• Azithromycin - for atypical organisms or respiratory co-infection
• Always culture first - choose antibiotic based on likely source and local sensitivity patterns

Summary